Newsroom

PARIS--(BUSINESS WIRE)--Lorient, une marque haut de gamme spécialisée dans l’esthétique, a annoncé avoir attiré l’attention mondiale lors du 27e IMCAS World Congress 2026 à Paris, qui a réuni plus de 15 000 professionnels et démontré son leadership en matière d’innovation esthétique. Le temps fort a été une session animée par Jani van Loghem, un leader d’opinion mondialement reconnu pour avoir établi des protocoles internationaux de sécurité esthétique. Sa participation a apporté une validation...

PARIS--(BUSINESS WIRE)--Lorient captured global attention at IMCAS 2026 with expert-led sessions, proving its excellence in safety and the effectiveness of its products....

PARIGI--(BUSINESS WIRE)--Lorient, un marchio di estetica di alta gamma, ha annunciato di aver attirato l'attenzione a livello globale in occasione della 27ª edizione di IMCAS World Congress 2026 tenutasi a Parigi e che ha attirato oltre 15.000 professionisti, dove ha dimostrato la propria leadership nell'ambito dell'innovazione estetica. Il momento clou è stato una sessione guidata dal dott. Jani van Loghem, un opinion leader rispettato a livello globale e noto per la creazione di protocolli di...

PARIS--(BUSINESS WIRE)--Lorient, eine Premium-Marke für ästhetische Medizin, gab bekannt, dass sie auf dem 27. IMCAS-Weltkongress 2026 in Paris weltweite Aufmerksamkeit auf sich gezogen hat, wo sie über 15.000 Fachleute anzog und ihre Führungsrolle im Bereich der ästhetischen Innovation unter Beweis stellte. Höhepunkt war eine Sitzung unter der Leitung von Dr. Jani van Loghem, einem weltweit angesehenen Meinungsführer, der für die Etablierung internationaler Sicherheitsprotokolle im Bereich der...

PARIJS--(BUSINESS WIRE)--Lorient, een premium esthetisch merk, heeft bekendgemaakt dat het wereldwijde aandacht heeft getrokken tijdens het 27e IMCAS World Congress 2026 in Parijs. Meer dan 15.000 professionals konden hier het leiderschap van het merk op het gebied van esthetische innovatie waarnemen. Het hoogtepunt was een sessie onder leiding van Dr. Jani van Loghem, een wereldwijd gerespecteerde opinieleider die bekend staat om het opstellen van internationale protocollen voor esthetische ve...

PARÍS--(BUSINESS WIRE)--Lorient, marca estética de alta gama, acaba de anunciar que ha acaparado la atención mundial en el 27.º Congreso Mundial IMCAS 2026 que se ha celebrado en París, al cual han acudido más de 15 000 profesionales y donde ha demostrado su liderazgo en innovación estética. El momento más destacado fue la sesión dirigida por el Dr. Jani van Loghem, referente mundial reconocido por establecer protocolos internacionales de seguridad estética. Su participación supuso un respaldo...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Maplebear Inc. d/b/a Instacart (NasdaqGS : CART). In December 2025, the U.S. Federal Trade Commission (FTC) announced a $60 million penalty against the company as a result of “deceiving consumers with false advertising, failure to provide refunds and unlawful subscription...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Lantheus Holdings, Inc. (NasdaqGM: LNTH). In August of 2025, contrary to the Company’s prior optimistic outlook for the growth potential of its flagship product, Pylarify, the Company disclosed an 8% year-over-year decline in Pylarify revenue, as well as cuts to its full-...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Inspire Medical Systems, Inc. (NYSE: INSP). In August of 2025, contrary to the Company’s repeated assurances that it had met all regulatory, technical, and commercial prerequisites for the launch of its Inspire V device, the Company disclosed that the launch faced an "elo...

SHANGHAI--(BUSINESS WIRE)--GAH and Tenacia announce a China commercialization partnership for ZTALMY, the first approved therapy for CDKL5 deficiency disorder....